Chitkara University confers 'Doctor of Literature' title upon Arvind Lal for contribution in healthcare
In his career, Brigadier Arvind Lal has won many accolades including the Padma Shri in 2009, EY Entrepreneur of the Year Award in Healthcare in 2019.
Careers360 Connect | May 31, 2024 | 06:28 PM IST
NEW DELHI: Chitkara University has conferred the esteemed title of Doctor of Literature (Honoris Causa) to (Hony) Brig Arvind Lal, Padma Shri, in recognition of his contributions to healthcare innovation, public health advancement, and philanthropy.
The convocation ceremony took place at Chitkara University's Punjab Campus to honour the achievements of Arvind Lal, Padma Shri.
This title underscores Lal's unwavering commitment to transforming healthcare landscapes and his unparalleled dedication to the betterment of society. Renowned as a visionary leader in laboratory services across India, Lal epitomises excellence in the healthcare sector.
“At Chitkara University, we are inspired by Arvind Lal's commitment to innovation and philanthropy," Ashok Chitkara, Chancellor, Chitkara University said. "His visionary leadership in healthcare has not only reshaped the industry but has also left a lasting impression on society. We take great pride in awarding Dr Lal the Honorary Degree of Doctor of Literature (Honoris Causa), acknowledging his remarkable contributions to healthcare and his enduring impact on India's future”, he added.
Visionary figure in healthcare domain
At the forefront of shaping public health discourse, Lal serves as the Chairman of FICCI’s Swasth Bharat (Public Health) Task Force, amplifying his influence on national healthcare agendas. His roles in organisations such as FICCI, NATHEALTH, and PHD Chambers further attest to his stature as a visionary figure in the healthcare domain.
Arvind Lal, an alumnus of the Armed Forces Medical College Pune, has been celebrated for his unparalleled dedication to advancing healthcare and societal well-being. His journey, marked by a commitment to pioneering primary healthcare interventions and nurturing spiritual enlightenment, underscores his compassionate approach to philanthropy. Through initiatives such as the ALVL Foundation, Lal has left an indelible mark on the landscape of healthcare in India.
As the Executive Chairman of Lal PathLabs Ltd, Lal's is known for his leadership which which has helped the company achieve success and establish itself as one of Asia's most prestigious laboratories.
Won many accolades including Padma Shri in 2009
Having received the esteemed Padma Shri in 2009, Lal has received a plethora of accolades over his career. Among these are the Business Standard Star SME of the Year 2021 and the EY Entrepreneur of the Year Award in Healthcare 2019, both of which attest to his substantial influence in the healthcare industry.
Disclaimer: This content was distributed by Manav Rachna and has been published as part of Careers360’s marketing initiative.
Follow us for the latest education news on colleges and universities, admission, courses, exams, research, education policies, study abroad and more..
To get in touch, write to us at news@careers360.com.
Next Story
]Featured News
]- ‘Being severely ragged’: Rajasthan MBBS student complains to UGC, NMC; Bhilwara medical college denies
- Bihar government cut absentees’ names from school rolls, violated teachers’ rights: PUCL
- Education News This Week: NEET reforms; PG counselling dates; JEE Main registration starts
- ‘Gross negligence’: NMC’s new MBBS curriculum guidelines can harm 3.6 crore Indians
- Library set up by IIT Delhi alumni helps students clear JEE Main, NEET, government job exams
- Time for the ‘wiki-thesis’: Rethinking research assessments in the age of AI writing
- Study Abroad: US, Germany more popular among foreign students; Canada, UK lose appeal, shows IDP survey
- Over 30,000 BTech seats in Karnataka vacant following surge in fee, intake
- Education News This Week: CBSE practical exam dates; IIT Delhi suicide; IIT Bombay’s facelift
- Maharashtra NEET UG Counselling 2024: Medical colleges draw ARA ire over admission denials, excess fee